Arabic Arabic English English French French German German
dark

IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock

IVERIC bio, Inc. (Nasdaq: ISEE) (the “Company”), today announced the pricing of an underwritten public offering of 11,650,000 shares of its common stock at a price to the public of $8.60 per share, less underwriting discounts and commissions Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Over 486,000 Prescriptions Dispensed through ‘Wasfaty’ Service in Al-Ahsa

Next Post

Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with Aviptadil in the I-SPY COVID Trial

Related Posts
Total
0
Share